![]() |
市場調查報告書
商品編碼
1504213
肺計量計的市場規模,佔有率,預測,趨勢分析:各產品,各技術,各用途,各終端用戶-2031年前的世界預測Spirometer Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer ) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User - Global Forecast to 2031 |
預計到 2031 年,全球肺活量計市場將達到 18 億美元,2024 年至 2031 年的複合年增長率為 9.2%。
該報告在廣泛的二級和一級研究以及對市場情景的深入分析後,對關鍵行業驅動因素、限制因素、課題和機會進行了分析。呼吸系統疾病盛行率上升、肺活量計技術進步、呼吸系統疾病意識提高以及對家庭醫療保健的偏好增加推動了肺活量計市場的成長。然而,肺活量計的高成本和缺乏熟練的專業人員限制了該市場的成長。
此外,市場參與者之間旨在開發肺活量計的聯盟和合作,以及新興國家不斷增長的需求,預計將為該市場的參與者提供成長機會。然而,替代技術的可用性對市場成長構成了重大課題。
(註:提供前 5 名公司 SWOT 分析)
Spirometers Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer [Incentive, Professional, Wireless, Handheld, Stationary, USB]) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User-Global Forecast to 2031
The global spirometers market is projected to reach $1.80 billion by 2031 at a CAGR of 9.2% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals restrain the growth of this market.
Furthermore, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to generate growth opportunities for the players operating in this market. However, the availability of alternative technologies poses a major challenge to market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global spirometers market are Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.)), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain).
Among all the products studied in this report, the devices segment is expected to account for the largest share of over 65.2% of the spirometers market. This segment's large market share can be attributed to the increasing approvals of spirometer devices, technological advancements in these devices, and their widespread adoption for monitoring disease progression.
Among all the technologies studied in this report, in 2024, the peak flow measurement segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the ease of use, portability, and cost-effectiveness of peak flow measurement spirometers. These devices are simpler to operate and require minimal setup compared to volume-based devices.
Among all the applications studied in this report, in 2024, the Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the high burden of chronic obstructive pulmonary disease (COPD). For instance, according to the National Institutes of Health (NIH), in 2022, 300 million people worldwide were diagnosed with COPD.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the rising cases of respiratory conditions such as asthma, COPD, and pulmonary fibrosis, leading to a significant number of patient visits to hospitals and clinics. For instance, according to the Australian Bureau of Statistics, in 2022, 2.8 million individuals were reported to have asthma in Australia.
An in-depth analysis of the geographical scenario of the global spirometers market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 41.6% of the spirometers market. In the region in 2024, the U.S. is expected to account for the largest share of the spirometers market in North America. The large share of the regional market is attributed to the increasing incidence of respiratory diseases leading to higher hospital admissions, the well-established healthcare sector, and the presence of prominent spirometer companies, such as Hill-Rom Holdings, Inc. (U.S.) and Midmark Corporation (U.S.), in this region.
Spirometers Market Assessment-by Product
Note: Other Spirometers include windmill-type spirometers and pneumotachometers.
Spirometers Market Assessment-by Technology
Spirometers Market Assessment-by Application
Note: Other Applications include bronchiectasis, lung cancer, emphysema, and chronic bronchitis.
Spirometers Market Assessment-by End User
Spirometers Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)